Presidio Investors Announces Sale of ElevATE Semiconductor to Diodes Incorporated
14.7.2026 16:56:00 CEST | Business Wire | Press release
Sale to Nasdaq-listed strategic acquirer marks successful realization of Presidio’s first continuation fund
Presidio Investors (“Presidio”), a lower middle market private equity firm, today announced that it has entered into a definitive agreement to sell ElevATE Semiconductor, Inc. (“ElevATE”) to Diodes Incorporated (Nasdaq: DIOD) in an all-cash transaction valued at $250 million. ElevATE, headquartered in San Diego, California, is a leading fabless designer of low-power, high-density integrated circuits for the automated test equipment (ATE) industry.
The sale marks the successful realization of Presidio’s first continuation fund, which was formed in 2023 to extend the firm’s partnership with ElevATE and support the company’s next phase of growth. The acquisition of ElevATE by a leading global semiconductor company validates the strategy behind the continuation vehicle and delivers a strong outcome for the company, its employees, and Presidio’s investors.
Presidio first invested in ElevATE in 2018, when the company was a small, founder-led team of analog chip designers serving the ATE market. Over nearly eight years of partnership — with Managing Partner Christian Puscasiu and Partner Josef Auboeck serving on ElevATE’s board of directors — Presidio worked alongside management to institutionalize operations, strengthen global sales channels, expand the product portfolio, and invest in the R&D capabilities that established ElevATE as a technology leader in semiconductor test. Along the way, the company adopted modern operating systems and AI-enabled tools that allowed the business to scale efficiently as demand grew. Today, ElevATE’s integrated circuits address the industry’s most complex ATE challenges, and demand for its solutions continues to grow with the accelerating production volumes of automotive, industrial, data center, and AI semiconductors.
“This is a proud day for everyone who has been part of the ElevATE journey,” said Christian Puscasiu, Managing Partner of Presidio Investors. “When we partnered with ElevATE’s founders in 2018, we saw a small team of world-class engineers with technology that punched far above its weight. The credit for what ElevATE has become belongs to its people — the founders who built the foundation, the engineers who kept pushing the technology forward, and Jan and his leadership team, who have taken the company to a new level. Diodes is an outstanding home for ElevATE, and we are grateful to the investors who backed this company alongside us at every stage.”
“Presidio has been a true partner to ElevATE from day one,” said Jan Gaudestad, Chief Executive Officer of ElevATE, who first joined the company’s board of directors at the time of Presidio’s 2018 investment and was appointed CEO in 2024. “I have seen this partnership from both the boardroom and the CEO seat. Presidio invested in our people, our operations, and our product roadmap, and gave us the stability and resources to focus on what we do best — designing the highest density, lowest power test solutions in the industry. This acquisition by Diodes is the direct result of that partnership, and it positions ElevATE to bring our innovations to a global stage. On behalf of the entire ElevATE team, I want to thank Chris and the Presidio team for eight years of support, trust, and genuine collaboration.”
The transaction has been approved by the boards of both companies and by ElevATE’s stockholders, and is expected to close during the second half of 2026, subject to customary closing conditions, including regulatory approvals.
BofA Securities Inc. served as exclusive financial advisor, and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. served as legal counsel to ElevATE and Presidio in connection with the transaction.
About ElevATE Semiconductor
ElevATE Semiconductor, Inc. is a fabless semiconductor company headquartered in San Diego, California, specializing in the development of integrated circuits for the automated test equipment (ATE) industry. ElevATE addresses the industry’s most complex ATE challenges by designing the lowest power and highest density solutions, with the goal of providing the lowest possible cost of test. For more information, please visit www.elevatesemi.com.
About Presidio Investors
Presidio Investors is a leading Austin, Texas-based private equity firm investing in quality businesses in the lower middle market. Presidio makes control investments in growing, niche companies and employs a collaborative approach to help grow and develop businesses to produce excellent returns for all stakeholders. Presidio principals have decades of private equity investing and operating experience, and the firm is committed to a technology-forward approach to value creation, partnering with its portfolio companies to deploy AI and modern operating tools that drive efficiency and growth. To learn more about Presidio, please visit www.presidioinvestors.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260714838577/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Garvan Institute of Medical Research Joins Parse Biosciences’ Certified Service Provider Network15.7.2026 22:00:00 CEST | Press release
Researchers across Asia-Pacific gain a new option for high-quality single cell sequencing through Garvan's Evercode WT services Parse Biosciences, a QIAGEN company, and the leader in scalable and accessible single cell sequencing, today announced that the Genomics Platform Core Facility within the Garvan Institute of Medical Research has joined its Certified Service Provider (CSP) Program. The partnership broadens access to high-quality, scalable single cell sequencing across Australia, the wider Asia-Pacific region, and beyond. Garvan is one of Australia's preeminent medical research institutions, with the Genomics Platform having deep experience in cell sorting, capture, and sequencing. As a Certified Service Provider, Garvan will offer Parse's Evercode WT kits to researchers across the region. "We see a growing number of requests for Parse projects and find the technology easy to implement and run, generating great data," said Chris O'Keeffe, Cellular Genomics Lead at the Garvan Ins
Grafana Labs Named a Leader in 2026 Gartner® Magic Quadrant™ for Observability Platforms and Positioned Furthest in Completeness of Vision15.7.2026 20:21:00 CEST | Press release
Named a Leader for the third consecutive year and placed furthest in vision for the second year in a row, the company has had a landmark year of innovation as observability becomes essential infrastructure for teams building and running AI at scale. Grafana Labs, the company behind the open observability cloud, today announced it has been named a Leader in the Gartner® Magic Quadrant™ for Observability Platforms for the third consecutive year, and positioned furthest on the Completeness of Vision axis for the second year running. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715814984/en/ 2026 Gartner® Magic Quadrant™ for Observability Platforms We believe this placement reflects where the market is headed: toward open, composable observability that helps teams in the AI era understand systems that are increasingly complex and agentic, and rapidly scaling thanks to AI-assisted engineering. A Platform Built for the AI Era
Spectro Cloud Raises $100 Million Series D to Help Customers Move AI Infrastructure Into Production Across Enterprise, Public Sector, Neocloud and Sovereign Cloud Environments15.7.2026 18:20:00 CEST | Press release
Growth Equity at Goldman Sachs Alternatives leads oversubscribed round with strategic participation from AMD Ventures, Ericsson, LG Technology Ventures, and Maximus as organizations look to turn AI silicon into business outcomes Spectro Cloud, a leading provider of AI infrastructure management software, today announced it has raised more than $100 million in an oversubscribed Series D funding round led by Growth Equity at Goldman Sachs Alternatives, with strategic participation from AMD Ventures, Ericsson, LG Technology Ventures, and Maximus. The new funding brings Spectro Cloud’s total capital raised to $260 million and will accelerate the company’s mission to help enterprises, public sector organizations, neoclouds and sovereign clouds build and operate production AI infrastructure with greater control over cost, security and governance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715551858/en/ Spectro Cloud raises $
K-Beauty Goes Global: Sales Surge 53% as Korean Innovation Reshapes Beauty Growth15.7.2026 16:00:00 CEST | Press release
New NIQ data shows K-Beauty value sales rose 53% year-over-year and 131% over two years, underscoring how regional beauty trends, social commerce and ingredient-led innovation are reshaping global beauty growth. NIQ (NYSE: NIQ), a global leader in consumer intelligence, today released new findings showing K-Beauty has become a rapidly growing global beauty segment, with value sales up 53% year-over-year and 131% over the past two years. The data points to a broader shift in beauty growth, as regional innovation, social commerce and digitally driven consumer demand increasingly shape what scales globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715867578/en/ K-Beauty accelerates across global markets In its latest report, K-Beauty Goes Global, NIQ shows how Korean beauty is reshaping consumer expectations, accelerating innovation cycles and redefining competitive dynamics across the global beauty market. What began
Viz.ai to Support the MINUTE Trial, a Landmark Multicenter Study Evaluating the SCUBA Technique for the Treatment of Intracerebral Hemorrhage15.7.2026 15:00:00 CEST | Press release
Viz Neuro™ Suite, including Viz ICH™ and Viz ICH Plus™, to facilitate rapid detection and care coordination for patients with basal ganglia hemorrhage across trial sites nationwide. Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced its support for the Minimally Invasive Neurosurgery Trial for Ultra-early Treatment (MINUTE) Trial, a prospective, multicenter, randomized study evaluating whether the SCUBA technique, an endoscopic, catheter-based approach for ultra-early evacuation of basal ganglia intracerebral hemorrhage (BGH), is a promising alternative to standard medical management to potentially improve functional patient outcomes. The study aims to initiate both randomization and surgical intervention within 120 minutes of key clinical time points, reflecting the urgent nature of intracerebral hemorrhage care. Participating sites will have the ability to leverage the Viz Neuro Suite platform, including Viz ICH and Viz ICH Plus, to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom